Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-12 in Metastatic or Recurrent Breast Cancer
NCT00004893Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 1999
- Primary completion
- Feb 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in breast cancer, sponsored by Cancer and Leukemia Group B. Started Dec 1999; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004893.